Comparative Study of Transurethral Plasmakinetic Resection and Enucleation in Treatment of Benign Prostatic Hyperplasia

Objective To explore the clinical effect of transurethral resectoscope enucleation of the prostate and transurethral plasmakinetic resection in patients with benign prostatic hyperplasia, and provide reference for safe and effective clinical treatment for prostate hyperplasia. Methods 116 patients with benign prostatic hyperplasia in our hospital from December 2008 to December 2010 were selected and randomly divided into observation group and control group. The observation group received transurethral resectoscope enucleation of the prostate, while the control group received transurethral plasmakinetic resection of the prostate. The clinical data including operation time, hospitalization time, costs and postoperative maximum urinary flow rate between two groups were compared. Results The operation time in the observation group was longer than that in the control group (P 0.05), while the intraoperative bleeding in the observation group was less than that in the control group; the differences of operation time and intraoperative bleeding between the two groups were statistically significant (P 0.05). The observation group had less hospitalization time and higher hospitalization expense compared with the control group, and the differences were statistically significant (P 0.05). The difference of postoperative maximum urinary flow rate between the two groups was not statistically significant (P 0.05). Conclusions The transurethral resectoscope enucleation of the prostate is an effective surgical method for treatment of benign prostatic hyperplasia with the advantages of less intraoperative blood loss, safety and efficiency.